Followers | 89 |
Posts | 4244 |
Boards Moderated | 1 |
Alias Born | 01/15/2008 |
Monday, November 10, 2008 10:33:42 PM
C/O Crossfield, Inc.
133 W 13th Street
New York, NY 10011
Phone: 212 727-7085
OTC Market Tier
Pink Quote/OTCBB
State Of Incorporation
DE
Jurisdiction Of Incorporation
United States
Company Officers
Robert E. Wolfe, President
SEC Reporting Status
SEC Reporting Company
CIK
0000352991
Fiscal Year End
6/30
Estimated Market Cap
$91,707 as of Nov 7, 2008
Outstanding Shares
45,853,585 as of Jun 30, 2008
Number of Share Holders of Record
1,563 as of Sep 18, 2008
Company Notes
Formerly=Aquanautics Corp. to 10-93
Security Notes
New Issue=7-81 2,000,000 shs in units (2 shs Com & 1 Warr 7-14-86) at $4.50 per unit by Sherwood Securities Corp.
Latest Addt'l Issue=12-85 180,000 shs in units (60 shs Com, 100 shs $10 7% Series 1 Pfd & 1 Class A Warr 12-13-90) at $1,000 per unit by D.H. Blair & Co., Inc.
Capital Change=10-27-93 shs decreased by 1 for 5 reverse split
Transfer Agent
New York Drop-Securities Transfer & Reporting Services, Inc.
Williams St. Galleria
New York City
Computershare Investor Services LLC
P.O. Box 43010
(150 Royall St. (Mail Stop 45-02-80))
Canton, MA 02021)
Providence, RI 02940-3010
--------------------------------------------------------------------------------
ADVANCED OXYGEN TECHNOLOGIES, INC.
AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY)
3 Months ending Year Ending
September 30, 2008 June 30, 2008
Unaudited
--------------------------------------------------------------------------------
Audited
--------------------------------------------------------------------------------
Common stock, par value $0.01, authorized, 90,000,000 shares; ------------- -------------
issued, as follows:
Balance at beginning and end of period 46,973,585 $ 469,736 $ 469,736
============= =============
Additional paid in capital:
Balance at beginning and end of period $ 20,497,769 $ 20,497,769
============= =============
Accumulated deficit:
Balance at beginning of period $ (20,752,862) $ (20,844,584)
Net income (loss) for the period 5,081 91,722
------------- -------------
Balance at end of period $ (20,747,781) $ (20,752,862)
Rounding: - -
============= =============
Other stockholders' deficiency accounts (no change during period )
Convertible preferred stock, net of treasury stock (see balance sheet ) $ 9,466 $ 9,466
============= =============
Stockholders' Equity (Deficiency) at end of period $ 229,190 $ 224,109
============= =============
See accompanying notes to financial statements.
Return to Table of Contents
--------------------------------------------------------------------------------
ADVANCED OXYGEN TECHNOLOGIES, INC.
Consolidated Statement of Cash Flow
3 Month Period Ending September 30
(unaudited)
2008
2007
Cash flow from operating activities
Net Income (Loss) 5,081 6,394
Adjustments to reconcile net loss to cash provided by operations
Accounts Receivable & Value Added Tax Receivable - -
Accounts Payable and Accrued Expenses (2,055) (1,632)
Taxes Payable 5,058 (833)
Current Portion of Long Term Debt - (56,620)
Client Escrow Funds, ANV - -
Prepaid Rental Revenues, ANV 21,424 8,122
Total Adjustments 24,427 (50,963)
Net Cash provided (used) by operations 29,508 (44,569)
Cash Flows from financing activities:
Proceeds From:
Note Payable, Crossfield 2,080 -
Proceeds Used For:
Long Term Debt (1,792)
Net Cash Flows used in Financing Activities: 288 -
Net Increase (decrease) in Cash 29,796 (44,569)
Cash Balance at beginning of Period 133,962 241,945
Cash Balance at End of Period 163,758 197,376
Recent AOXY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/24/2024 09:12:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 06:16:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM